WSO December 2023 – Issue 3 - 1227

Moutzouri et al.
1227
25. Feng X, Tang Q, Cheng C and Xu S. Low serum lipid levels,
use of statin and cerebral microbleeds: a systematic review
and meta-analysis. J Clin Neurosci 2021; 94: 216-225.
26. Lee SH, Lee ST, Kim BJ, Park HK, Kim CK, Jung KH and
Roh JK. Dynamic temporal change of cerebral microbleeds:
long-term follow-up MRI study. PLoS ONE 2011; 6: e25930.
27. Xiong Y, Wong A, Cavalieri M, et al. Prestroke statins, progression
of white matter hyperintensities, and cognitive
decline in stroke patients with confluent white matter hyperintensities.
Neurotherapeutics 2014; 11: 606-611.
28. Ding J, Sigurdsson S, Garcia M, et al. Risk factors associated
with incident cerebral microbleeds according to location
in older people: the age, gene/environment susceptibility
(AGES)-Reykjavik study. JAMA Neurol 2015; 72: 682-688.
29. Violi F, Calvieri C, Ferro D and Pignatelli P. Statins as
antithrombotic drugs. Circulation 2013; 127: 251-257.
30. Stangier J, Rathgen K, Stähle H, Reseski K, Körnicke T and
Roth W. Coadministration of dabigatran etexilate and atorvastatin:
assessment of potential impact on pharmacokinetics and
pharmacodynamics. Am J Cardiovasc Drugs 2009; 9: 59-68.
31. Charidimou A, Karayiannis C, Song TJ, et al. Brain microbleeds,
anticoagulation, and hemorrhage risk: meta-analysis
in stroke patients with AF. Neurology 2017; 89: 2317-2326.
32. Tsivgoulis G, Zand R, Katsanos AH, et al. Risk of symptomatic
intracerebral hemorrhage after intravenous thrombolysis in
patients with acute ischemic stroke and high cerebral microbleed
burden: a meta-analysis. JAMA Neurol 2016; 73: 675-683.
33. Wilson D, Ambler G, Shakeshaft C, et al. Cerebral microbleeds
and intracranial haemorrhage risk in patients anticoagulated
for atrial fibrillation after acute ischaemic stroke or
transient ischaemic attack (CROMIS-2): a multicentre observational
cohort study. Lancet Neurol 2018; 17: 539-547.
34. Greenberg SM, Eng JA, Ning M, Smith EE and Rosand J.
Hemorrhage burden predicts recurrent intracerebral hemorrhage
after lobar hemorrhage. Stroke 2004; 35: 1415-
1420.
35. Choi KH, Seo WK, Park MS, et al. Effect of statin therapy
on outcomes of patients with acute ischemic stroke and atrial
fibrillation. J Am Heart Assoc 2019; 8: e013941.
36. Aeschbacher-Germann M, Kaiser N, Speierer A, et al. Lipidlowering
trials are not representative of patients managed in
clinical practice: a systematic review and meta-analysis of
exclusion criteria. J Am Heart Assoc 2023; 12: e026551.
37. Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide
epidemiology of atrial fibrillation: a global burden of disease
2010 study. Circulation 2014; 129: 837-847.
38. Umemura T, Mashita S and Kawamura T. Oral anticoagulant
use and the development of new cerebral microbleeds in cardioembolic
stroke patients with atrial fibrillation. PLoS ONE
2020; 15: e0238456.
39. Ingala S, Mazzai L, Sudre CH, et al. The relation between
APOE genotype and cerebral microbleeds in cognitively
unimpaired middle- and old-aged individuals. Neurobiol
Aging 2020; 95: 104-114.
International Journal of Stroke, 18(10)
WSO December 2023 – Issue 3

Table of Contents for the Digital Edition of WSO December 2023 – Issue 3
